Literature DB >> 26246652

A Bayesian hierarchical model for inference across related reverse phase protein arrays experiments.

Riten Mitra1, Peter Müller2, Yuan Ji3, Yitan Zhu3, Gordon Mills4, Yiling Lu4.   

Abstract

We consider inference for functional proteomics experiments that record protein activation over time following perturbation under different dose levels of several drugs. The main inference goal is the dependence structure of the selected proteins. A critical challenge is the lack of sufficient data under any one drug and dose level to allow meaningful inference on dependence structure. We propose a hierarchical model to implement the desired inference. The key element of the model is a shared dependence structure on (latent) binary indicators of protein activation.

Entities:  

Keywords:  Bayesian; graphical; hierarchical model; protein networks; timecourse

Year:  2014        PMID: 26246652      PMCID: PMC4523276          DOI: 10.1080/02664763.2014.920776

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.404


  14 in total

1.  Using Bayesian networks to analyze expression data.

Authors:  N Friedman; M Linial; I Nachman; D Pe'er
Journal:  J Comput Biol       Date:  2000       Impact factor: 1.479

2.  A Bayesian networks approach for predicting protein-protein interactions from genomic data.

Authors:  Ronald Jansen; Haiyuan Yu; Dov Greenbaum; Yuval Kluger; Nevan J Krogan; Sambath Chung; Andrew Emili; Michael Snyder; Jack F Greenblatt; Mark Gerstein
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

3.  Cluster-based network model for time-course gene expression data.

Authors:  Lurdes Y T Inoue; Mauricio Neira; Colleen Nelson; Martin Gleave; Ruth Etzioni
Journal:  Biostatistics       Date:  2006-09-15       Impact factor: 5.899

4.  Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

Authors:  Xianjun Fang; Shuangxing Yu; Janos L Tanyi; Yiling Lu; James R Woodgett; Gordon B Mills
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

6.  A time-series DDP for functional proteomics profiles.

Authors:  Luis E Nieto-Barajas; Peter Müller; Yuan Ji; Yiling Lu; Gordon B Mills
Journal:  Biometrics       Date:  2012-01-05       Impact factor: 2.571

7.  Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin.

Authors:  Han C Dan; Mei Sun; Lin Yang; Richard I Feldman; Xue-Mei Sui; Chien Chen Ou; Mark Nellist; Raymond S Yeung; Dicky J J Halley; Santo V Nicosia; Warren J Pledger; Jin Q Cheng
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

8.  Differential expression and network inferences through functional data modeling.

Authors:  Donatello Telesca; Lurdes Y T Inoue; Mauricio Neira; Ruth Etzioni; Martin Gleave; Colleen Nelson
Journal:  Biometrics       Date:  2008-11-13       Impact factor: 2.571

9.  Dynamic deterministic effects propagation networks: learning signalling pathways from longitudinal protein array data.

Authors:  Christian Bender; Frauke Henjes; Holger Fröhlich; Stefan Wiemann; Ulrike Korf; Tim Beissbarth
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

10.  Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced human trophoblast migration.

Authors:  Qing Qiu; Mingyan Yang; Benjamin K Tsang; Andrée Gruslin
Journal:  Mol Hum Reprod       Date:  2004-07-02       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.